16 Nov, 2022 Press Releases Curevo Vaccine Announces $26 Million Series A1 Financing to Support Clinical Development of Next-Generation Subunit Vaccines by curevovaccine
10 Feb, 2022 News, Press Releases, Vaccines Curevo Vaccine Announces $60 Million Series A Financing to Support Clinical Development of Next Generation Subunit Vaccines by curevovaccine
15 Sep, 2020 News, Vaccines Curevo Vaccine Announces Robust Antibody Response Results of Phase I Clinical Trial of Investigational Vaccine for Shingles CRV-101 by curevovaccine
26 Sep, 2019 News, Press Releases, Vaccines Curevo Vaccine Announces Interim Results of Phase I Clinical Trial of CRV-101 by curevovaccine
